The ESMO Sarcoma and Rare Cancers Congress 2025 promises to be an excellent platform for the exchange of cutting-edge research, innovative therapeutic approaches, and collaborative discussions aimed at advancing this field of oncology.

The ESMO Sarcoma and Rare Cancers Congress 2025 scientific and educational programme will delve into the latest developments in diagnosis, treatment modalities, biology, and molecular classification of rare solid tumours, offering attendees a comprehensive overview of the rapidly evolving landscape in this specialised area.

Whether you are a seasoned oncologist, a dedicated researcher, a healthcare professional, a pharmaceutical industry leader, or a patient advocate, this event offers something for everyone committed to advancing the care and improving outcomes of patients with sarcomas and rare cancers.

We look forward to welcoming you to Lugano, for an unforgettable experience of learning, collaboration, and discovery at the forefront of oncology.